Kathleen R. Schildroth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathleen R. Schildroth has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Justin L. Gottlieb
University of Wisconsin, Department of Ophthalmology and Visual Sciences, Madison, WI, USA
4 shared publications- Jonathan S. Chang
Clinical Eye Research Unit, Dept of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
3 shared publications - Michael M. Altaweel
Clinical Eye Research Unit, Dept of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
3 shared publications Michael S. Ip
University of Wisconsin, Department of Ophthalmology and Visual Sciences, Madison, WI, USA
3 shared publications- Siva S Radhakrishnan Iyer
Department of Ophthalmology, University of Florida, Gainesville, Florida, USA
3 shared publications - Albert L. Lin
Department of Ophthalmology, University of Mississippi Medical Center, Jackson, MS, USA
2 shared publications
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 20 (4) , 540-544
SCLEROCHOROIDAL CALCIFICATION PRESENTING WITH UNILATERAL FULL-THICKNESS MACULAR HOLE: PRESENTATION AND SUCCESSFUL SURGICAL CLOSURE
Purpose: Describe a case of macular hole (MH) presenting in a patient with sclerochoroidal calcification (SCC). Only one previous case of an MH in the setting of SCC has previously been reported; however, that case was observed without surgery. We present a case of an MH in SCC in which successful surgical closure and visual acuity improvement were achieved. Methods: Case report. Results: A 70-year-old man presented for retinal evaluation of metamorphopsia with a visual acuity of 20/25 in the right eye and 20/300 in the left eye. Fundoscopic examination showed bilateral SCC. Ultrasonographic B-scan examination of the left eye was consistent with SCC. An optical coherence tomography showed a full thickness MH in the left eye, and surgical repair with pars plana vitrectomy, internal limiting membrane peel, and gas was performed. Postoperatively, the visual acuity in the left eye was 20/50; the examination and optical coherence tomography showed anatomic success with closure of the MH and stable SCC lesions. Conclusion: SCC may be associated with full thickness MH, possibly secondary to tangential traction from the elevated lesion. Despite the SCC lesion, successful MH closure may be achieved with typical maneuvers of vitrectomy, internal limiting membrane peel, and gas.
- 1 July 2026
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 20 (4) , 540-544
SCLEROCHOROIDAL CALCIFICATION PRESENTING WITH UNILATERAL FULL-THICKNESS MACULAR HOLE: PRESENTATION AND SUCCESSFUL SURGICAL CLOSURE
Purpose: Describe a case of macular hole (MH) presenting in a patient with sclerochoroidal calcification (SCC). Only one previous case of an MH in the setting of SCC has previously been reported; however, that case was observed without surgery. We present a case of an MH in SCC in which successful surgical closure and visual acuity improvement were achieved. Methods: Case report. Results: A 70-year-old man presented for retinal evaluation of metamorphopsia with a visual acuity of 20/25 in the right eye and 20/300 in the left eye. Fundoscopic examination showed bilateral SCC. Ultrasonographic B-scan examination of the left eye was consistent with SCC. An optical coherence tomography showed a full thickness MH in the left eye, and surgical repair with pars plana vitrectomy, internal limiting membrane peel, and gas was performed. Postoperatively, the visual acuity in the left eye was 20/50; the examination and optical coherence tomography showed anatomic success with closure of the MH and stable SCC lesions. Conclusion: SCC may be associated with full thickness MH, possibly secondary to tangential traction from the elevated lesion. Despite the SCC lesion, successful MH closure may be achieved with typical maneuvers of vitrectomy, internal limiting membrane peel, and gas.
- Open Access
- 1 May 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (7) , 101207
Comparison of Clarus, Optos, and Heidelberg Systems for Geographic Atrophy Area Measurements
- 1 May 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (7) , 101207
Open AccessComparison of Clarus, Optos, and Heidelberg Systems for Geographic Atrophy Area Measurements
- 25 September 2025
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (1) , 116-121
Intraocular Pressure Control and Long-Term Outcomes With the Reservoir Technique: The Wisconsin Silicone Oil Study (Report 2)
Purpose: To evaluate the long-term outcomes of silicone oil (SO) tamponade using the reservoir technique vs standard oil fill technique for complex vitreoretinal surgery. Methods: This retrospective comparative case series evaluated 313 SO tamponade surgeries (230 eyes). In the reservoir technique, the posterior segment is filled with SO. The infusion line is temporarily opened to atmosphere, allowing SO to egress into the line, creating the reservoir. The pressurized air infusion is then reset to 15 mm Hg to maintain a complete SO fill during sclerotomy closure. In the palpation method, SO is introduced without creating a reservoir or moderating infusion pressure, and digital palpation of the globe determines adequate fill. Results: Moderately severe ocular hypertension (intraocular pressure [IOP] ≥30 mm Hg) occurred less frequently in the reservoir group (1.6%) compared with the palpation group (9.3%; P = .005). Prolonged ocular hypertension (IOP ≥25 mm Hg for ≥2 visits) was also less frequent in the reservoir group (2.9% vs 9.1%; P = .02). SO emulsification was less frequent in the reservoir group (2.7% vs 9.4%; P = .04). Eyes in the reservoir group required fewer SO placement surgeries (1.2 vs 1.5 surgeries per eye; P = .01), while final anatomic success rates were similar (reservoir: 80.4%, palpation: 78.2%; P = .5). Visual outcomes were comparable between groups. Conclusions: The reservoir technique for SO tamponade placement reduces the risk of IOP elevation, minimizes the need for reoperation, and decreases SO complications. These findings support the reservoir technique as a reliable and consistent method for SO placement in complex vitreoretinal surgeries.
- 25 September 2025
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (1) , 116-121
Intraocular Pressure Control and Long-Term Outcomes With the Reservoir Technique: The Wisconsin Silicone Oil Study (Report 2)
Purpose: To evaluate the long-term outcomes of silicone oil (SO) tamponade using the reservoir technique vs standard oil fill technique for complex vitreoretinal surgery. Methods: This retrospective comparative case series evaluated 313 SO tamponade surgeries (230 eyes). In the reservoir technique, the posterior segment is filled with SO. The infusion line is temporarily opened to atmosphere, allowing SO to egress into the line, creating the reservoir. The pressurized air infusion is then reset to 15 mm Hg to maintain a complete SO fill during sclerotomy closure. In the palpation method, SO is introduced without creating a reservoir or moderating infusion pressure, and digital palpation of the globe determines adequate fill. Results: Moderately severe ocular hypertension (intraocular pressure [IOP] ≥30 mm Hg) occurred less frequently in the reservoir group (1.6%) compared with the palpation group (9.3%; P = .005). Prolonged ocular hypertension (IOP ≥25 mm Hg for ≥2 visits) was also less frequent in the reservoir group (2.9% vs 9.1%; P = .02). SO emulsification was less frequent in the reservoir group (2.7% vs 9.4%; P = .04). Eyes in the reservoir group required fewer SO placement surgeries (1.2 vs 1.5 surgeries per eye; P = .01), while final anatomic success rates were similar (reservoir: 80.4%, palpation: 78.2%; P = .5). Visual outcomes were comparable between groups. Conclusions: The reservoir technique for SO tamponade placement reduces the risk of IOP elevation, minimizes the need for reoperation, and decreases SO complications. These findings support the reservoir technique as a reliable and consistent method for SO placement in complex vitreoretinal surgeries.
- 1 September 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (5) , 665-667
EXOGENOUS TESTOSTERONE USE AND ACUTE CENTRAL SEROUS CHORIORETINOPATHY IN A TRANSGENDER PATIENT
Purpose: To describe the presentation and clinical course of a transgender patient with central serous chorioretinopathy (CSCR) and discuss the role of exogenous testosterone use in CSCR in this patient population. Method: Case report. Results: A 63-year-old transgender male patient with a history of exogenous testosterone use for over 20 years was referred to a retina clinic for evaluation of macular pathology. The patient's most recent total testosterone levels before presentation were 962 and 1,179 ng/dL (normal cis-gender male levels for age 60+: 300–720 ng/dL). Fundus imaging revealed subretinal fluid involving the fovea without choroidal neovascularization in the right eye. There was no recent corticosteroid use. The patient's dose of testosterone was reduced. After four months of observation, the subretinal fluid persisted and was successfully treated with half-fluence photodynamic therapy (PDT). At the last follow-up, 15 months after PDT, the patient remained stable without recurrence and the best-corrected visual acuity was at baseline. Conclusion: Exogenous testosterone use with elevated serum testosterone levels may be associated with the development of central serous chorioretinopathy in the transgender patient population. CSCR in these patients might be effectively treated with PDT and testosterone dose reduction. Ophthalmologists should be aware of the potential side effects of testosterone supplementation in this patient population and the role of testosterone in CSCR pathophysiology.
- 1 September 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (5) , 665-667
EXOGENOUS TESTOSTERONE USE AND ACUTE CENTRAL SEROUS CHORIORETINOPATHY IN A TRANSGENDER PATIENT
Purpose: To describe the presentation and clinical course of a transgender patient with central serous chorioretinopathy (CSCR) and discuss the role of exogenous testosterone use in CSCR in this patient population. Method: Case report. Results: A 63-year-old transgender male patient with a history of exogenous testosterone use for over 20 years was referred to a retina clinic for evaluation of macular pathology. The patient's most recent total testosterone levels before presentation were 962 and 1,179 ng/dL (normal cis-gender male levels for age 60+: 300–720 ng/dL). Fundus imaging revealed subretinal fluid involving the fovea without choroidal neovascularization in the right eye. There was no recent corticosteroid use. The patient's dose of testosterone was reduced. After four months of observation, the subretinal fluid persisted and was successfully treated with half-fluence photodynamic therapy (PDT). At the last follow-up, 15 months after PDT, the patient remained stable without recurrence and the best-corrected visual acuity was at baseline. Conclusion: Exogenous testosterone use with elevated serum testosterone levels may be associated with the development of central serous chorioretinopathy in the transgender patient population. CSCR in these patients might be effectively treated with PDT and testosterone dose reduction. Ophthalmologists should be aware of the potential side effects of testosterone supplementation in this patient population and the role of testosterone in CSCR pathophysiology.
- 1 May 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (3) , 346-348
A CASE OF RHEGMATOGENOUS RETINAL DETACHMENT IN CHRONIC MYELOID LEUKEMIA
Purpose: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by uncontrolled proliferation of granulocytes, caused the BCR-ABL1 fusion gene. While ocular manifestations of CML are rare, the presentations can range from asymptomatic to sudden vision loss. Chronic myeloid leukemia-associated ocular findings that have been reported include retinal hemorrhages, leukemic infiltrates, and optic disc edema, but a rhegmatogenous retinal detachment in the setting of CML has not been described. Methods: This was a case report. Results: A 21-year-old man presented with intermittent vision loss in his right eye, tinnitus in the right ear, and abdominal distension. Workup revealed significant leukocytosis, splenomegaly, and a positive BCR-ABL1 mutation. He was diagnosed with CML and started on systemic therapy. Examination of the right eye revealed a large intraocular mass. After 2 weeks of systemic treatment, the large elevation in the right eye had improved, allowing visualization of diffuse subretinal whitening. At follow-up, a rhegmatogenous retinal detachment secondary to an atrophic hole in an area of prior subretinal infiltrates was noted. He underwent repair with a scleral buckle. Postoperative course was complicated by redetachment with proliferative vitreoretinopathy, which led to an unrepairable detachment, despite multiple surgeries with silicone oil tamponade. Conclusion: Ocular findings related to CML are rare, with the lowest incidence when compared with other leukemias, and are associated with worse outcomes. Posterior segment findings include intraretinal hemorrhages, Roth spots, and retinal infiltrates. This unique case describes a rhegmatogenous retinal detachment in CML retinopathy with an aggressive course and poor anatomical result.
- 1 May 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (3) , 346-348
A CASE OF RHEGMATOGENOUS RETINAL DETACHMENT IN CHRONIC MYELOID LEUKEMIA
Purpose: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by uncontrolled proliferation of granulocytes, caused the BCR-ABL1 fusion gene. While ocular manifestations of CML are rare, the presentations can range from asymptomatic to sudden vision loss. Chronic myeloid leukemia-associated ocular findings that have been reported include retinal hemorrhages, leukemic infiltrates, and optic disc edema, but a rhegmatogenous retinal detachment in the setting of CML has not been described. Methods: This was a case report. Results: A 21-year-old man presented with intermittent vision loss in his right eye, tinnitus in the right ear, and abdominal distension. Workup revealed significant leukocytosis, splenomegaly, and a positive BCR-ABL1 mutation. He was diagnosed with CML and started on systemic therapy. Examination of the right eye revealed a large intraocular mass. After 2 weeks of systemic treatment, the large elevation in the right eye had improved, allowing visualization of diffuse subretinal whitening. At follow-up, a rhegmatogenous retinal detachment secondary to an atrophic hole in an area of prior subretinal infiltrates was noted. He underwent repair with a scleral buckle. Postoperative course was complicated by redetachment with proliferative vitreoretinopathy, which led to an unrepairable detachment, despite multiple surgeries with silicone oil tamponade. Conclusion: Ocular findings related to CML are rare, with the lowest incidence when compared with other leukemias, and are associated with worse outcomes. Posterior segment findings include intraretinal hemorrhages, Roth spots, and retinal infiltrates. This unique case describes a rhegmatogenous retinal detachment in CML retinopathy with an aggressive course and poor anatomical result.
- 1 November 2024
- Published by Wolters Kluwer Health in Retina
- Vol. 44 (11) , 1931-1936
SUPPLEMENTAL DEXTROSE IN THE INFUSION FLUID DURING DIABETIC VITRECTOMY
Purpose: Historically, supplemental dextrose to infusion fluid has been used to reduce the need for intraoperative lensectomies to maintain visualization during diabetic vitrectomy. Valved, small-gauge vitrectomy has reduced surgical time and decreased intraoperative fluid flow. Assessment of supplemental dextrose in modern vitrectomy is presented in this study. Methods: A retrospective cohort study of diabetic patients undergoing vitrectomy was conducted. The dextrose group received supplemental dextrose in the infusion fluid, while the nondextrose group used a standard balanced salt solution (BSS Plus). Group assignment was per surgeons' typical practice patterns. Eyes with tractional retinal detachments were also evaluated as a subgroup. Results: Three hundred thirty phakic eyes were included. Supplemental dextrose was used in 199 eyes (60.3%). One unplanned lensectomy was performed in this series, in the nondextrose group, not statistically different from the dextrose group, with zero lensectomies (P = 0.4). Cataract survival curves overlapped for all eyes and for the tractional retinal detachment subgroup. Conclusion: In modern vitrectomy, unplanned lensectomy is rare. No difference was observed in the rate of intraoperative lensectomies or overall postoperative cataract course with or without dextrose supplementation to the infusion fluid. Standard solutions appear to be adequate for infusion, even for diabetics.
- 1 November 2024
- Published by Wolters Kluwer Health in Retina
- Vol. 44 (11) , 1931-1936
SUPPLEMENTAL DEXTROSE IN THE INFUSION FLUID DURING DIABETIC VITRECTOMY
Purpose: Historically, supplemental dextrose to infusion fluid has been used to reduce the need for intraoperative lensectomies to maintain visualization during diabetic vitrectomy. Valved, small-gauge vitrectomy has reduced surgical time and decreased intraoperative fluid flow. Assessment of supplemental dextrose in modern vitrectomy is presented in this study. Methods: A retrospective cohort study of diabetic patients undergoing vitrectomy was conducted. The dextrose group received supplemental dextrose in the infusion fluid, while the nondextrose group used a standard balanced salt solution (BSS Plus). Group assignment was per surgeons' typical practice patterns. Eyes with tractional retinal detachments were also evaluated as a subgroup. Results: Three hundred thirty phakic eyes were included. Supplemental dextrose was used in 199 eyes (60.3%). One unplanned lensectomy was performed in this series, in the nondextrose group, not statistically different from the dextrose group, with zero lensectomies (P = 0.4). Cataract survival curves overlapped for all eyes and for the tractional retinal detachment subgroup. Conclusion: In modern vitrectomy, unplanned lensectomy is rare. No difference was observed in the rate of intraoperative lensectomies or overall postoperative cataract course with or without dextrose supplementation to the infusion fluid. Standard solutions appear to be adequate for infusion, even for diabetics.
- 14 May 2024
- Published by Springer Nature in Eye
- Vol. 38 (14) , 2731-2736
The Wisconsin silicone oil study (report #1): anatomical and functional outcomes of repair of retinal detachment with proliferative vitreoretinopathy
Background Silicone oil (SO) is a long-term tamponade for repair of complex retinal pathology but has limitations including late redetachment. This study describes our experience with SO tamponade for repair of retinal detachment with proliferative vitreoretinopathy (PVR), with attention to anatomic and functional outcomes. Methods Retrospective consecutive case series of eyes with retinal detachment (RD) complicated by proliferative vitreoretinopathy (PVR) receiving SO tamponade at the University of Wisconsin between 2013 and 2019. Group 1 defined as primary SO placement; Group 2 had SO placed after failing prior retinal detachment repair. Results Inclusion criteria of SO placement for repair of RD with PVR was met for 117 eyes. The final reattachment rate was 84% for all eyes, with no difference between Groups 1 and 2. Vision improvement was 2.1 lines for Group 1 (p = 0.06 from baseline) and 4.6 lines for Group 2 (p < 0.0001). The mean number of silicone oil placements was 1.4. Less improvement in vision was noted with repeat SO placement, though overall functional vision of 5/200 or better was achieved in 63.2% of patients. Conclusions SO tamponade allows long-term anatomical stabilisation and substantial vision recovery in eyes with retinal detachment complicated by PVR. Rates of anatomic and functional success have improved significantly when compared to prior studies using oil tamponade for repair of PVR.
- 14 May 2024
- Published by Springer Nature in Eye
- Vol. 38 (14) , 2731-2736
The Wisconsin silicone oil study (report #1): anatomical and functional outcomes of repair of retinal detachment with proliferative vitreoretinopathy
Background Silicone oil (SO) is a long-term tamponade for repair of complex retinal pathology but has limitations including late redetachment. This study describes our experience with SO tamponade for repair of retinal detachment with proliferative vitreoretinopathy (PVR), with attention to anatomic and functional outcomes. Methods Retrospective consecutive case series of eyes with retinal detachment (RD) complicated by proliferative vitreoretinopathy (PVR) receiving SO tamponade at the University of Wisconsin between 2013 and 2019. Group 1 defined as primary SO placement; Group 2 had SO placed after failing prior retinal detachment repair. Results Inclusion criteria of SO placement for repair of RD with PVR was met for 117 eyes. The final reattachment rate was 84% for all eyes, with no difference between Groups 1 and 2. Vision improvement was 2.1 lines for Group 1 (p = 0.06 from baseline) and 4.6 lines for Group 2 (p < 0.0001). The mean number of silicone oil placements was 1.4. Less improvement in vision was noted with repeat SO placement, though overall functional vision of 5/200 or better was achieved in 63.2% of patients. Conclusions SO tamponade allows long-term anatomical stabilisation and substantial vision recovery in eyes with retinal detachment complicated by PVR. Rates of anatomic and functional success have improved significantly when compared to prior studies using oil tamponade for repair of PVR.
- Open Access
Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges
Background and Objectives: Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a peripheral retinal vascular abnormality that is likely underreported. We review the differential diagnoses, etiology, and treatment options for PEHCR. Methods: We present a case of an asymptomatic 72-year-old female referred following left eye fundus photography finding of the peripheral lesion. Results: Fundus photography demonstrated a large temporal pigment epithelial detachment (PED) with adjacent fibrovascular membrane. Optical coherence tomography (OCT) confirmed the PED with trace subretinal fluid. Fluorescein angiography (FA) demonstrated early and late hypofluorescence of the PED with late leakage of the adjacent temporal fibrovascular membrane. Observation was elected, visual acuity remained unaffected, and the PED spontaneously resolved. Conclusions: Due to the peripheral location, patients often present as asymptomatic; however, vision loss can occur due to vitreous hemorrhage or extension of subretinal fluid, hemorrhage, or exudate to the macula. Commonly, these lesions are referred with concern for choroidal melanoma due to their large, dark, elevated presentation in the peripheral retina. Multimodal testing using B-scan, FA, and OCT is important in establishing the proper diagnosis. PEHCR lesions can often be observed without treatment, though intravitreal injection of anti-VEGF is increasingly used to prevent secondary causes of vision loss.
Open AccessPeripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges
Background and Objectives: Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a peripheral retinal vascular abnormality that is likely underreported. We review the differential diagnoses, etiology, and treatment options for PEHCR. Methods: We present a case of an asymptomatic 72-year-old female referred following left eye fundus photography finding of the peripheral lesion. Results: Fundus photography demonstrated a large temporal pigment epithelial detachment (PED) with adjacent fibrovascular membrane. Optical coherence tomography (OCT) confirmed the PED with trace subretinal fluid. Fluorescein angiography (FA) demonstrated early and late hypofluorescence of the PED with late leakage of the adjacent temporal fibrovascular membrane. Observation was elected, visual acuity remained unaffected, and the PED spontaneously resolved. Conclusions: Due to the peripheral location, patients often present as asymptomatic; however, vision loss can occur due to vitreous hemorrhage or extension of subretinal fluid, hemorrhage, or exudate to the macula. Commonly, these lesions are referred with concern for choroidal melanoma due to their large, dark, elevated presentation in the peripheral retina. Multimodal testing using B-scan, FA, and OCT is important in establishing the proper diagnosis. PEHCR lesions can often be observed without treatment, though intravitreal injection of anti-VEGF is increasingly used to prevent secondary causes of vision loss.
- Open Access
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 13
Effect of pattern scanning laser on macular thickness in diabetic retinopathy
This study investigates the effect of pattern scanning laser (PASCAL) panretinal photocoagulation (PRP) on central macular thickness (CMT) and visual acuity (VA) in patients with proliferative diabetic retinopathy (PDR). This retrospective non-randomized comparative case series included 262 eyes (163 with macular edema) of 177 patients with PDR. Treatment was PRP alone (137), PRP + anti-vascular endothelial growth factor (VEGF) (69), PRP + focal laser (28), or all three (89). CMT and central macular volume 3 and 6 mm from fovea were analyzed before and 1, 3, and 6 months after PRP. Spot number was plotted against CMT, and linear regression analysis was performed. For each treatment group and time point, there was a non-significant relationship between spot number and CMT. In eyes receiving all three treatment modalities, a significant negative relationship was found between spot number and 3-mm volume at 6 months (p = 0.04) and 6-mm volume at 1 month (p = 0.002) and 6 months (p = 0.011). There was no significant change in VA in any treatment group at the 6-month time point. PASCAL PRP ± focal laser or anti-VEGF was not associated with increased development of macular edema or change in VA. PASCAL PRP with focal laser and anti-VEGF may result in a decrease in macular edema.
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 13
Open AccessEffect of pattern scanning laser on macular thickness in diabetic retinopathy
This study investigates the effect of pattern scanning laser (PASCAL) panretinal photocoagulation (PRP) on central macular thickness (CMT) and visual acuity (VA) in patients with proliferative diabetic retinopathy (PDR). This retrospective non-randomized comparative case series included 262 eyes (163 with macular edema) of 177 patients with PDR. Treatment was PRP alone (137), PRP + anti-vascular endothelial growth factor (VEGF) (69), PRP + focal laser (28), or all three (89). CMT and central macular volume 3 and 6 mm from fovea were analyzed before and 1, 3, and 6 months after PRP. Spot number was plotted against CMT, and linear regression analysis was performed. For each treatment group and time point, there was a non-significant relationship between spot number and CMT. In eyes receiving all three treatment modalities, a significant negative relationship was found between spot number and 3-mm volume at 6 months (p = 0.04) and 6-mm volume at 1 month (p = 0.002) and 6 months (p = 0.011). There was no significant change in VA in any treatment group at the 6-month time point. PASCAL PRP ± focal laser or anti-VEGF was not associated with increased development of macular edema or change in VA. PASCAL PRP with focal laser and anti-VEGF may result in a decrease in macular edema.
- Open Access
- 9 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7451
Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy is a potentially blinding sequela of uncontrolled diabetes that involves a complex interaction of pro-angiogenic and inflammatory pathways. In this study, we compared the levels of pro-angiogenic arachidonic acid-derived mediators in human vitreous humor obtained from eyes with high-risk proliferative diabetic retinopathy versus controls. The results indicated that lipoxygenase and cytochrome P450-derived eicosanoids were elevated (5-HETE, 12-HETE, 20-HETE, and 20-COOH-AA), and there appeared to be no differences in levels measured in eyes with tractional retinal detachments versus those without. These results provide further insight into the pathogenesis of this disease and for the development of future potential therapeutic agents that target arachidonic acid metabolites to treat diabetic retinopathy.
- 9 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7451
Open AccessEicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy is a potentially blinding sequela of uncontrolled diabetes that involves a complex interaction of pro-angiogenic and inflammatory pathways. In this study, we compared the levels of pro-angiogenic arachidonic acid-derived mediators in human vitreous humor obtained from eyes with high-risk proliferative diabetic retinopathy versus controls. The results indicated that lipoxygenase and cytochrome P450-derived eicosanoids were elevated (5-HETE, 12-HETE, 20-HETE, and 20-COOH-AA), and there appeared to be no differences in levels measured in eyes with tractional retinal detachments versus those without. These results provide further insight into the pathogenesis of this disease and for the development of future potential therapeutic agents that target arachidonic acid metabolites to treat diabetic retinopathy.